プロテオミクス市場- 世界の産業規模、シェア、動向、機会、予測、2018年～2028年製品別、技術別、用途別、タイプ別、エンドユーザー別、地域別、競合別分析

世界のプロテオミクス市場は、2022年に271億8,000万米ドルと評価され、2028年までのCAGRは12.71%で、予測期間中に目覚ましい成長を遂げると予測されています。

プロテオミクスは、プロテオームを大規模に研究する重要な分野です。プロテオミクスは、疾患関連タンパク質の同定や、その産生、機能、構造の調査に利用される強力な技術です。プロテオミクスは、がん、感染症、マラリア、結核を含む様々な疾患の予後マーカーの発見や診断に重要な役割を果たしています。さらに製薬分野では、薬物の作用や毒性のメカニズムを解明するためにプロテオミクスが広く用いられています。さらに、バイオマーカーの同定と検証にも一般的に応用されています。プロテオームは、生物内のすべてのメッセンジャーRNA分子を包含するトランスクリプトームの影響を部分的に受けています。しかし、タンパク質の活性は、遺伝子発現レベル以外にも様々な要因の影響を受ける。プロテオミクスの応用範囲は広いです。

タンパク質間の相互作用や代謝経路への関与の解明に加え、プロテオミクスはタンパク質の発現パターン、生産・分解速度、定常状態の存在量の調査を可能にします。また、タンパク質の機能を変化させるリン酸化などの翻訳後修飾の研究も可能です。さらに、プロテオミクスは、ミトコンドリアなどの特定の細胞区画に存在するタンパク質の種類や、睡眠と覚醒のサイクルを制御し、約24時間ごとに繰り返される概日リズムのような生物学的プロセスに関与するタンパク質についての洞察を提供します。

典型的なプロテオミクス実験の目的は、タンパク質の位置、存在量／ターンオーバー、翻訳後修飾に関する情報を収集することです。この目的のために、Tandem-MSのような質量分析（MS）ベースの技術や、DIGEのようなゲルベースの技術など、様々なハイスループット技術が開発されており、これらはプロテオミクス研究で広く採用されています。

市場促進要因

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 プロテオミクスの世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別（試薬・アッセイ、装置、ソフトウェア・サービス）
  • 技術別（分光法、マイクロアレイ装置、クロマトグラフィー、X線結晶構造解析、タンパク質マイクロアレイ、電気泳動）
  • アプリケーション別（臨床診断、創薬、診断バイオマーカー探索、その他）
  • タイプ別（発現,機能,構造,計算）
  • エンドユーザー別（製薬・バイオテクノロジー企業、研究機関、CRO）
  • 地域別
  • 企業別（2022年）
• 市場マップ

第6章 北米プロテオミクス市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 技術別
  • アプリケーション別
  • タイプ別
  • エンドユーザー別
  • 国別
• 北米国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州プロテオミクス市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 技術別
  • アプリケーション別
  • タイプ別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋プロテオミクス市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 技術別
  • アプリケーション別
  • タイプ別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米プロテオミクス市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 技術別
  • アプリケーション別
  • タイプ別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカプロテオミクス市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • 技術別
  • アプリケーション別
  • タイプ別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 プロテオミクスの世界市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Business Overview
• Service Offerings
• Recent Developments
• Key Personnel
• SWOT Analysis
  • Illumina, Inc.
  • Thermo Fisher Scientific Company Profile
  • Bruker Corporation
  • Promega Corporation
  • Agilent Technologies Inc. Company Profile
  • Merck KGaA.
  • Bio-Rad Laboratories, Inc. Company Profile
  • Danaher Corporation Company Profile
  • F Hoffmann-La Roche Ltd.
  • Luminex Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Proteomics Market has valued at USD 27.18 Billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 12.71% through 2028. Proteomics, the study of proteomes on a large scale, is a crucial field. Proteomics is a powerful technique utilized for the identification of disease-associated proteins and the investigation of their production, function, and structure. It plays a crucial role in the discovery of prognostic markers and the diagnosis of various diseases, including cancer, infectious illnesses, malaria, and tuberculosis. Moreover, in the pharmaceutical sector, proteomics is extensively employed to elucidate the mechanisms of drug action and toxicity. Additionally, it is commonly applied in the identification and validation of biomarkers. The proteome is partially influenced by the underlying transcriptome, which encompasses all messenger RNA molecules in an organism. However, protein activity is influenced by various factors beyond gene expression levels. Proteomics has a wide range of applications.

In addition to elucidating protein-protein interactions and their involvement in metabolic pathways, proteomics enables the investigation of protein expression patterns, production and degradation rates, and steady-state abundance. It also allows the study of post-translational modifications, such as phosphorylation, which can alter protein function. Moreover, proteomics provides insights into the types of proteins present in specific cellular compartments, such as the mitochondrion, and the proteins involved in biological processes like the circadian rhythm, which regulates the sleep-wake cycle and repeats approximately every 24 hours.

A typical proteomic experiment aims to gather information about a protein's location, abundance/turnover, and post-translational modifications. Various high-throughput technologies have been developed for this purpose, including mass spectrometry (MS)-based techniques like Tandem-MS, as well as gel-based techniques such as differential in-gel electrophoresis (DIGE), which are widely employed in proteomic studies.

Key Market Drivers

Increase In the Number of Patients Suffering from Cancer

The increasing incidence of cancer and other disorders is another crucial factor contributing to the growth of the global proteomics market. With the rising number of cancer cases worldwide, there is a pressing need for effective treatment options. This has resulted in extensive research and development in the field of life sciences, leading to significant advancements and discoveries.

One major breakthrough in this field is the characterization of human proteins, which has revolutionized the field of biomedicine. By studying gene expression at the proteome level, researchers can gain deeper insights into the intricate mechanisms underlying diseases like cancer. This constant research and development in the field of proteomics are anticipated to fuel the market's growth to a great extent. Through the application of proteomics techniques, researchers are able to extract highly significant biological information that greatly enhances our understanding of cancer biology. This knowledge can ultimately benefit patients by improving diagnosis, treatment, and overall patient care.

The continuous advancements in proteomics research not only help in identifying how proteins respond in dynamic environments, such as cancer patients, but also pave the way for the development of personalized medicine. By tailoring treatment plans based on an individual's unique proteomic profile, healthcare providers can maximize the effectiveness of therapies and minimize side effects. The increasing prevalence of cancer, along with the constant progress in proteomics research, holds immense potential for the global proteomics market. The ability to extract valuable insights from the proteome level opens up new opportunities for advancements in diagnosis, treatment, and personalized medicine, ultimately benefiting patients worldwide.

Increased Investments In R&D In Proteomics

The National Institutes of Health (NIH), a renowned institution in the United States, generously contributed a staggering amount of US$ 37 billion towards groundbreaking biomedical research. This substantial grant was specifically allocated to support life sciences research, aiming to deepen our understanding of the fundamental mechanisms underlying the occurrence of diseases. By investing in cutting-edge technologies and state-of-the-art facilities, the NIH is empowering scientists and researchers to explore novel approaches in disease prevention, diagnosis, and treatment.

The NIH's commitment to advancing the frontiers of medical knowledge extends beyond the identification of crucial biomarkers and unraveling the complex interplay of genes and proteins. It encompasses a multidisciplinary approach that integrates genomics, proteomics, metabolomics, and other emerging fields to gain comprehensive insights into disease mechanisms.

Through collaborative initiatives and partnerships with leading academic institutions and industry experts, the NIH fosters a vibrant ecosystem of discovery and innovation. This remarkable investment not only fuels breakthroughs in basic research but also supports the translation of scientific findings into tangible improvements in patient care. With its unwavering dedication to scientific excellence, the NIH is paving the way for advancements in the field of healthcare. By catalyzing transformative discoveries and nurturing the next generation of scientists, the NIH plays a pivotal role in shaping the future of medicine and improving human health and well-being on a global scale.

Rising Demand for Personalized Medicine

The rising demand for personalized medicine has spurred a significant increase in the demand for proteomics, a field of study dedicated to understanding the complex and dynamic world of proteins within the human body. Personalized medicine represents a paradigm shift in healthcare, moving away from the one-size-fits-all approach and toward tailoring medical treatments to an individual's unique genetic makeup, lifestyle, and disease profile. Proteomics plays a pivotal role in this transformation by providing valuable insights into the proteome, the complete set of proteins expressed by an organism.

With the advent of high-throughput technologies such as mass spectrometry and advanced bioinformatics tools, proteomics has become a powerful tool in deciphering the intricate molecular mechanisms underlying diseases. It enables researchers to identify specific protein markers associated with various medical conditions, allowing for early disease detection, precise diagnosis, and the development of targeted therapies. For instance, in oncology, proteomics has facilitated the discovery of novel biomarkers that aid in predicting a patient's response to cancer treatments, thereby optimizing therapy choices.

Furthermore, proteomics is instrumental in understanding the intricacies of drug interactions with proteins, paving the way for the development of personalized drug regimens. By analyzing an individual's protein profile, healthcare providers can determine the most effective and safest medications, minimizing adverse effects and improving overall treatment outcomes.

Technological Advancements

The advancement of cutting-edge tools that significantly enhance the productivity, throughput, and speed of biological research is poised to revolutionize the field and foster rapid market expansion. State-of-the-art 2-D electrophoresis protein analyzers, equipped with advanced algorithms and innovative technologies, offer an unparalleled ability to accurately analyze complex protein samples.

These advanced analyzers not only provide high precision and efficiency, but they also empower researchers with a comprehensive suite of features. With their advanced image analysis capabilities, researchers can precisely identify and quantify proteins, even in low-abundance samples. The integration of innovative automation technologies allows for seamless sample handling and processing, minimizing human error and maximizing throughput. Additionally, the analyzers are equipped with intuitive software interfaces that streamline data analysis and visualization, enabling researchers to uncover valuable insights from their experiments more quickly.

By empowering researchers to uncover valuable insights and accelerate breakthrough discoveries, these advanced analyzers have the potential to propel the field of biological research to new heights. With exceptional precision and efficiency, they pave the way for further growth and innovation in the industry, opening up exciting possibilities for scientists and researchers worldwide. With their ability to handle complex protein samples and provide detailed analysis, these analyzers are revolutionizing the way biological research is conducted, enabling scientists to delve deeper into the intricacies of life at the molecular level.

Key Market Challenges

Expensive Instruments

The need for a longer period of time in laboratories increases the cost of treatment. This is primarily due to the expensive instruments and reagents used in the process, which limits the use of this technology in developing nations. One of the most commonly used methods in proteomics is X-ray crystallography. This method involves protein expression, gene cloning, protein crystallization, and purification. However, these procedures are time-consuming, resulting in higher costs. As a result, the adoption of these procedures in developing nations is limited. This presents a significant challenge to the growth of the market and will continue to hinder its progress in the long run.

To overcome this obstacle and promote market growth in developing nations, it is crucial to expand the accessibility and affordability of these technologies. By doing so, more laboratories and research institutions in these regions will be able to utilize these advanced techniques to study proteins and contribute to scientific advancements. This, in turn, can lead to improved healthcare solutions, better understanding of diseases, and the development of targeted therapies.

Furthermore, addressing the cost issue can also encourage collaborations between developed and developing nations in the field of proteomics. By sharing resources, knowledge, and expertise, it becomes possible to overcome the financial limitations and accelerate the progress of research and innovation. This collaborative approach can create a more inclusive and globally connected scientific community, where breakthroughs in proteomics are not limited by economic constraints.

The longer time required and higher costs associated with proteomic research in laboratories pose challenges to its widespread adoption in developing nations. However, by expanding the accessibility, affordability, and fostering international collaborations, we can overcome these obstacles and promote market growth in these regions. This will not only advance scientific knowledge but also contribute to improving healthcare outcomes for people around the world.

Experimental Challenges in Protein Structure Determination

One of the major challenges hindering the growth of the global proteomics market is the experimental difficulties associated with determining protein structures. Protein structure determination is a complex and intricate process that often requires the utilization of multiple techniques and expertise. Current methods, such as X-ray crystallography and NMR spectroscopy, although widely used, have their limitations and may not always yield successful results. The determination of protein structures becomes even more challenging when dealing with large, multi-domain proteins, membrane proteins, and proteins with flexible regions.

In addition to these challenges, the detection of post-translational modifications (PTMs) and the significant cost and time required for protein structure determination pose significant obstacles to the advancement of the field. The identification and characterization of PTMs play a crucial role in understanding protein function and regulation, but their detection can be technically demanding and time-consuming.

To overcome these challenges and foster the growth of the proteomics market, it is imperative to develop new techniques, improve existing methods, and encourage interdisciplinary collaboration. The inherent instability and flexibility of proteins present challenges that extend across various aspects of proteomics, impeding the market's progress in the forecast period. By addressing these experimental challenges and advancing our understanding of protein structures and functions, we can unlock new opportunities for innovation and drive the future development of the proteomics field.

Key Market Trends

Emergence Of Label-Free Quantification Techniques

The emergence of label-free quantification techniques is a major trend in the market. The global proteomics market has witnessed notable trends, including the rise of label-free quantification techniques. Label-free quantification, a revolutionary approach in proteomics, utilizes mass spectrometry-based methods to accurately measure proteins without the need for chemical or isotopic labels. By eliminating the use of labels, this technique offers enhanced accuracy, reproducibility, and cost-effectiveness, making it an attractive option for researchers. Moreover, label-free quantification enables the analysis of larger sample sizes, allowing for more comprehensive proteomic studies. Additionally, this approach avoids potential artifacts that may arise from labeling interference, ensuring the integrity of the protein quantification results. As the demand for high-throughput, reliable, and cost-effective proteomic analysis continues to grow, the adoption of label-free quantification techniques is expected to increase rapidly in the coming years, revolutionizing the field of proteomics and advancing our understanding of complex biological systems.

Integration of Artificial Intelligence

Artificial intelligence in proteomics is a well-known and rapidly growing trend in the field. The use of artificial intelligence in proteomics applications is already making significant advancements in the field of drug development. By considering how and why specific proteins interact, researchers can better understand the complexities of cell biology and determine the potential therapeutic or harmful effects of new medications.

In addition to the impact of artificial intelligence, there are several other market trends that are driving the expansion of the proteome market. The rise in drug discovery efforts, fueled by advancements in technology, is leading to the development of innovative proteomic technologies and techniques. Nano proteomics, in particular, is gaining increasing significance as it allows for the analysis of proteins at the nanoscale, providing valuable insights into their structure and function.

Furthermore, the advancement of proteomic technology is enabling new applications in various fields, including diagnostics, personalized medicine, and biomarker discovery. These advancements are expected to further accelerate the growth of the proteome market over the forecast period, opening up new opportunities for research and development in the field of proteomics.

Segmental Insights

Product Insights

The reagents & assays segment accounted for the highest share in the global revenue in 2022. This segment is expected to experience the fastest growth rate during the projected period. The significant growth can be attributed to the extensive use of reagents & consumables, kits, chemicals, and strips for the examination of various biological samples. These resources are widely utilized in academic institutions, research labs, and other establishments, thereby driving the demand for reagents & consumables and fueling the growth of this segment.

Moreover, the market growth is further supported by the technological advancements in advanced instruments, such as 2-D electrophoresis protein analyzers. These innovative instruments enhance the speed, efficiency, and throughput of biological research, providing researchers with valuable tools to conduct their experiments and investigations. With such advancements, the market is expected to witness a positive growth trajectory in the coming years.

Technology Insights

Based on the latest advancements in technologies, the proteomics market is broadly segmented into various techniques and tools that enable comprehensive protein analysis. These include Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, and Electrophoresis. Among these, spectroscopy emerged as the leading technique in 2022, capturing the largest share of the proteomics market for instrumentation technologies.

The dominance of spectroscopy can be attributed to its widespread utilization in studying proteins and gaining insights into their structures, interactions, and functions. Spectroscopic techniques offer valuable information about the properties of proteins, including their secondary and tertiary structures, conformational changes, and ligand binding. By leveraging spectroscopy, researchers and scientists can delve deeper into the intricacies of protein behavior, facilitating advancements in various fields, such as drug discovery, diagnostics, and personalized medicine.

The continuous evolution and innovation in spectroscopy, along with its ability to provide detailed and precise protein analysis, make it an indispensable tool in the proteomics field. As researchers strive to unlock the mysteries of complex biological systems at the molecular level, spectroscopy remains a vital component in their quest for knowledge and breakthrough discoveries.

Regional Insights

North America emerged as the dominant player, generating substantial revenue throughout the projected period. The growth of omics research, the need for reliable data reproducibility tools, and the focus on personalized treatments all contribute to this trend. Additionally, the market's expansion is facilitated by strategic alliances and collaborations among key regional enterprises. A notable example is the partnership between Symphogen and Thermo Fisher Scientific Inc., aimed at developing standardized platform methods for the efficient characterization and quality monitoring of complex therapeutic proteins.

The Asia-Pacific region is projected to experience the highest growth rate between 2024 and 2028. This growth can be attributed to several factors, including the outsourcing of proteomics-based projects, both public and private funding for proteomics research and development, favorable government regulations, increasing adoption of proteomics leading to a rise in target disease prevalence, and an aging population. For example, in November, the University of Hyderabad received a million-dollar grant from the Department of Biotechnology of the Indian Government to study the tomato proteome. Government initiatives supporting proteomics research play a pivotal role in driving the growth of the Asia-Pacific market.

Key Market Players

Illumina, Inc.

Thermo Fisher Scientific Company Profile

Bruker Corporation

Promega Corporation

Agilent Technologies Inc. Company Profile

Merck KGaA.

Bio-Rad Laboratories, Inc. Company Profile

Danaher Corporation Company Profile

F Hoffmann-La Roche Ltd.

Luminex Corporation

Report Scope:

In this report, the Global Proteomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Proteomics Market, By Product:

• Reagents & Assays
• Instruments
• Software & Services

Proteomics Market, By Technology:

• Spectroscopy
• Microarray instruments
• Chromatography
• X-ray crystallography
• Protein Microarrays
• Electrophoresis

Proteomics Market, By Application:

• Clinical Diagnostic
• Drug Discovery
• Diagnostic Biomarker Discovery
• Others

Proteomics Market, By Type:

• Expression
• Functional
• Structural
• Computational

Proteomics Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Research Institutes
• CROs

Proteomics Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Proteomics Market.

Available Customizations:

• Global Proteomics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Proteomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Reagents and Assays, Instruments, Software & Services)
  • 5.2.2. By Technology (Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, Electrophoresis)
  • 5.2.3. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
  • 5.2.4. By Type (Expression, Functional, Structural, Computational)
  • 5.2.5. By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
  • 5.2.6. By Region
  • 5.2.7. By Company (2022)
• 5.3. Market Map

6. North America Proteomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By Type
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Proteomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Type
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Proteomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Type
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Proteomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Type
      • 6.3.3.2.5. By End User

7. Europe Proteomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By Type
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Proteomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Type
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Proteomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Type
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Proteomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Type
      • 7.3.3.2.5. By End User
  • 7.3.4. France Proteomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Type
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Proteomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Type
      • 7.3.5.2.5. By End User

8. Asia-Pacific Proteomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By Type
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Proteomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Type
      • 8.3.1.2.5. By End User
  • 8.3.2. India Proteomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Type
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Proteomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Type
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Proteomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Type
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Proteomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Type
      • 8.3.5.2.5. By End User

9. South America Proteomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By Type
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Proteomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Type
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Proteomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Type
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Proteomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Type
      • 9.3.3.2.5. By End User

10. Middle East and Africa Proteomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By Type
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Proteomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Type
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Proteomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Type
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Proteomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Type
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Proteomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Illumina, Inc.
  • 15.5.2. Thermo Fisher Scientific Company Profile
  • 15.5.3. Bruker Corporation
  • 15.5.4. Promega Corporation
  • 15.5.5. Agilent Technologies Inc. Company Profile
  • 15.5.6. Merck KGaA.
  • 15.5.7. Bio-Rad Laboratories, Inc. Company Profile
  • 15.5.8. Danaher Corporation Company Profile
  • 15.5.9. F Hoffmann-La Roche Ltd.
  • 15.5.10. Luminex Corporation

16. Strategic Recommendations

17. About Us & Disclaimer